Download PDF
Clin Colon Rectal Surg 2023; 36(01): 063-073
DOI: 10.1055/s-0042-1758770
Review Article

Anastomotic Considerations in Crohn's Disease

Brian R. Kann
1   Department of Colon & Rectal Surgery, Ochsner Health, New Orleans, Louisiana
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

A number of factors should be considered when performing an intestinal anastomosis in the setting of surgery for Crohn's disease. Preoperative risk factors, such as malnutrition, abdominal sepsis, and immunosuppressive medications, may increase the risk of postoperative anastomotic complications and alter surgical decision-making. The anatomical configuration and technique of constructing the anastomosis may have an impact on postoperative function and risk of recurrence, particularly in the setting of ileocolic resection, where the Kono-S anastomosis has gained popularity in recent years. There may be circumstances in which it may be more appropriate to perform an ostomy either without an anastomosis or to temporarily divert an anastomosis when the risk of anastomotic complications is felt to be high. In the setting of total abdominal colectomy or proctocolectomy for Crohn's colitis, restorative procedures may appropriate in lieu of a permanent stoma in certain scenarios.

Keywords

Crohn's disease - anastomosis - Kono-S


Publication History

Article published online:
09 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000; 231 (01) 38-45
    CrossrefPubMedGoogle Scholar
  • 2 Vester-Andersen MK, Prosberg MV, Jess T. et al. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Am J Gastroenterol 2014; 109 (05) 705-714
    CrossrefPubMedGoogle Scholar
  • 3 Steele S, Hull TL, Hyman N, Maykel JA, Read TE, Whitlow CB. American Society of Colon and Rectal Surgeons. The ASCRS Textbook of Colon and Rectal Surgery. 4th ed.. New York: Springer; 2022
    CrossrefGoogle Scholar
  • 4 Cao Q, Huang YH, Jiang M, Dai C. The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients. Scand J Gastroenterol 2019; 54 (12) 1458-1466
    CrossrefPubMedGoogle Scholar
  • 5 Swaminath A, Feathers A, Ananthakrishnan AN, Falzon L, Li Ferry S. Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease. Aliment Pharmacol Ther 2017; 46 (07) 645-656
    CrossrefPubMedGoogle Scholar
  • 6 Yamamoto T, Shiraki M. Efficacy of enteral nutrition during infliximab maintenance therapy in patients with Crohn's disease. Dig Dis Sci 2013; 58 (06) 1802-1803
    CrossrefPubMedGoogle Scholar
  • 7 Mijac DD, Janković GL, Jorga J, Krstić MN. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med 2010; 21 (04) 315-319
    CrossrefPubMedGoogle Scholar
  • 8 Valentini L, Schulzke JD. Mundane, yet challenging: the assessment of malnutrition in inflammatory bowel disease. Eur J Intern Med 2011; 22 (01) 13-15
    CrossrefPubMedGoogle Scholar
  • 9 Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum 2000; 43 (08) 1141-1145
    Google Scholar
  • 10 Myrelid P, Olaison G, Sjödahl R, Nyström PO, Almer S, Andersson P. Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease. Dis Colon Rectum 2009; 52 (08) 1387-1394
    CrossrefPubMedGoogle Scholar
  • 11 Post S, Betzler M, von Ditfurth B, Schürmann G, Küppers P, Herfarth C. Risks of intestinal anastomoses in Crohn's disease. Ann Surg 1991; 213 (01) 37-42
    CrossrefPubMedGoogle Scholar
  • 12 Shental O, Tulchinsky H, Greenberg R, Klausner JM, Avital S. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease. Dis Colon Rectum 2012; 55 (11) 1125-1130
    CrossrefPubMedGoogle Scholar
  • 13 Tay GS, Binion DG, Eastwood D, Otterson MF. Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery 2003; 134 (04) 565-572 , discussion 572–573
    CrossrefPubMedGoogle Scholar
  • 14 Reindl W, Thomann AK, Galata C, Kienle P. Reducing perioperative risks of surgery in Crohn's disease. Visc Med 2019; 35 (06) 348-354
    CrossrefPubMedGoogle Scholar
  • 15 Ferrandis C, Souche R, Bardol T. et al. Personalized pre-habilitation reduces anastomotic complications compared to up front surgery before ileocolic resection in high-risk patients with Crohn's disease: a single center retrospective study. Int J Surg 2022; 105: 106815
    CrossrefPubMedGoogle Scholar
  • 16 Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999; 134 (01) 36-42
    CrossrefPubMedGoogle Scholar
  • 17 Tzivanakis A, Singh JC, Guy RJ, Travis SP, Mortensen NJ, George BD. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery. Dis Colon Rectum 2012; 55 (05) 558-562
    CrossrefPubMedGoogle Scholar
  • 18 Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 2007; 50 (03) 331-336
    CrossrefPubMedGoogle Scholar
  • 19 Morar PS, Hodgkinson JD, Thalayasingam S. et al. Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn's disease-considerations in pre-operative and peri-operative optimisation techniques to improve outcome. J Crohn's Colitis 2015; 9 (06) 483-491
    CrossrefPubMedGoogle Scholar
  • 20 Kanazawa A, Yamana T, Okamoto K, Sahara R. Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease. Dis Colon Rectum 2012; 55 (09) 957-962
    CrossrefPubMedGoogle Scholar
  • 21 Iesalnieks I, Kilger A, Glass H. et al. Intraabdominal septic complications following bowel resection for Crohn's disease: detrimental influence on long-term outcome. Int J Colorectal Dis 2008; 23 (12) 1167-1174
    CrossrefPubMedGoogle Scholar
  • 22 Crowell KT, Messaris E. Risk factors and implications of anastomotic complications after surgery for Crohn's disease. World J Gastrointest Surg 2015; 7 (10) 237-242
    CrossrefPubMedGoogle Scholar
  • 23 Heimann TM, Greenstein AJ, Mechanic L, Aufses Jr AH. Early complications following surgical treatment for Crohn's disease. Ann Surg 1985; 201 (04) 494-498
    CrossrefPubMedGoogle Scholar
  • 24 Resegotti A, Astegiano M, Farina EC. et al. Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn's disease surgery. Dis Colon Rectum 2005; 48 (03) 464-468
    CrossrefPubMedGoogle Scholar
  • 25 Huang W, Tang Y, Nong L, Sun Y. Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: a meta-analysis of observational studies. J Crohn's Colitis 2015; 9 (03) 293-301
    CrossrefPubMedGoogle Scholar
  • 26 Lavorini E, Allaix ME, Ammirati CA, Astegiano M, Morino M, Resegotti A. Late is too late? Surgical timing and postoperative complications after primary ileocolic resection for Crohn's disease. Int J Colorectal Dis 2022; 37 (04) 843-848
    CrossrefPubMedGoogle Scholar
  • 27 Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 2003; 125 (02) 320-327
    CrossrefPubMedGoogle Scholar
  • 28 Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 2008; 12 (10) 1730-1736 , discussion 1736–1737
    CrossrefPubMedGoogle Scholar
  • 29 Colombel JF, Loftus Jr EV, Tremaine WJ. et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99 (05) 878-883
    CrossrefPubMedGoogle Scholar
  • 30 Kasparek MS, Bruckmeier A, Beigel F. et al. Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery. Inflamm Bowel Dis 2012; 18 (07) 1207-1213
    CrossrefPubMedGoogle Scholar
  • 31 Kjeldsen J, Nielsen J, Larsen MD, Qvist N, Nørgård BM. Postoperative use of anti-TNF-α agents in patients with Crohn's disease and risk of reoperation-a nationwide cohort study. Inflamm Bowel Dis 2016; 22 (03) 599-606
    CrossrefPubMedGoogle Scholar
  • 32 Krane MK, Allaix ME, Zoccali M. et al. Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease. Dis Colon Rectum 2013; 56 (04) 449-457
    CrossrefPubMedGoogle Scholar
  • 33 Canedo J, Lee SH, Pinto R, Murad-Regadas S, Rosen L, Wexner SD. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?. Colorectal Dis 2011; 13 (11) 1294-1298
    CrossrefPubMedGoogle Scholar
  • 34 Cohen BL, Fleshner P, Kane SV. et al. Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra-abdominal surgery. Gastroenterology 2022; 163 (01) 204-221
    CrossrefPubMedGoogle Scholar
  • 35 Law CCY, Narula A, Lightner AL, McKenna NP, Colombel JF, Narula N. Systematic review and meta-analysis: preoperative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease. J Crohn's Colitis 2018; 12 (05) 538-545
    CrossrefPubMedGoogle Scholar
  • 36 Yung DE, Horesh N, Lightner AL. et al. Systematic review and meta-analysis: vedolizumab and postoperative complications in inflammatory bowel disease. Inflamm Bowel Dis 2018; 24 (11) 2327-2338
    CrossrefPubMedGoogle Scholar
  • 37 Moosvi Z, Duong JT, Bechtold ML, Nguyen DL. Systematic review and meta-analysis: preoperative vedolizumab and postoperative complications in patients with IBD. South Med J 2021; 114 (02) 98-105
    CrossrefPubMedGoogle Scholar
  • 38 Lightner AL, McKenna NP, Tse CS. et al. Postoperative outcomes in Ustekinumab-treated patients undergoing abdominal operations for Crohn's disease. J Crohn's Colitis 2018; 12 (04) 402-407
    CrossrefPubMedGoogle Scholar
  • 39 Novello M, Stocchi L, Holubar S. et al. Surgical outcomes of patients treated with Ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis. Int J Colorectal Dis 2019; 34 (03) 451-457
    CrossrefPubMedGoogle Scholar
  • 40 Lightner AL, Vogel JD, Carmichael JC. et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the surgical management of Crohn's disease. Dis Colon Rectum 2020; 63 (08) 1028-1052
    Google Scholar
  • 41 Simillis C, Purkayastha S, Yamamoto T, Strong SA, Darzi AW, Tekkis PP. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease. Dis Colon Rectum 2007; 50 (10) 1674-1687
    CrossrefPubMedGoogle Scholar
  • 42 He X, Chen Z, Huang J. et al. Stapled side-to-side anastomosis might be better than handsewn end-to-end anastomosis in ileocolic resection for Crohn's disease: a meta-analysis. Dig Dis Sci 2014; 59 (07) 1544-1551
    CrossrefPubMedGoogle Scholar
  • 43 Guo Z, Li Y, Zhu W, Gong J, Li N, Li J. Comparing outcomes between side-to-side anastomosis and other anastomotic configurations after intestinal resection for patients with Crohn's disease: a meta-analysis. World J Surg 2013; 37 (04) 893-901
    CrossrefPubMedGoogle Scholar
  • 44 Celentano V, Pellino G, Spinelli A. et al; SICCR Current status of Crohn's disease surgery collaborative, on behalf of the Italian Society of Colorectal Surgery SICCR. Anastomosis configuration and technique following ileocaecal resection for Crohn's disease: a multicentre study. Updates Surg 2021; 73 (01) 149-156
    CrossrefPubMedGoogle Scholar
  • 45 Gajendran M, Bauer AJ, Buchholz BM. et al. Ileocecal anastomosis type significantly influences long-term functional status, quality of life, and healthcare utilization in postoperative Crohn's disease patients independent of inflammation recurrence. Am J Gastroenterol 2018; 113 (04) 576-583
    CrossrefPubMedGoogle Scholar
  • 46 Muñoz-Juárez M, Yamamoto T, Wolff BG, Keighley MR. Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn's disease. Dis Colon Rectum 2001; 44 (01) 20-25 , discussion 25–26
    CrossrefPubMedGoogle Scholar
  • 47 Scarpa M, Ruffolo C, Bertin E. et al. Surgical predictors of recurrence of Crohn's disease after ileocolonic resection. Int J Colorectal Dis 2007; 22 (09) 1061-1069
    CrossrefPubMedGoogle Scholar
  • 48 Kono T, Ashida T, Ebisawa Y. et al. A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn's disease. Dis Colon Rectum 2011; 54 (05) 586-592
    CrossrefPubMedGoogle Scholar
  • 49 Kono T, Fichera A, Maeda K. et al. Kono-S anastomosis for surgical prophylaxis of anastomotic recurrence in Crohn's disease: an international multicenter study. J Gastrointest Surg 2016; 20 (04) 783-790
    CrossrefPubMedGoogle Scholar
  • 50 Shimada N, Ohge H, Kono T. et al. Surgical recurrence at anastomotic site after bowel resection in Crohn's disease: comparison of Kono-S and end-to-end anastomosis. J Gastrointest Surg 2019; 23 (02) 312-319
    CrossrefPubMedGoogle Scholar
  • 51 Luglio G, Rispo A, Imperatore N. et al. Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn's disease: the SuPREMe-CD Study – a randomized clinical trial. Ann Surg 2020; 272 (02) 210-217
    CrossrefPubMedGoogle Scholar
  • 52 Alshantti A, Hind D, Hancock L, Brown SR. The role of Kono-S anastomosis and mesenteric resection in reducing recurrence after surgery for Crohn's disease: a systematic review. Colorectal Dis 2021; 23 (01) 7-17
    CrossrefPubMedGoogle Scholar
  • 53 Carr ND, Pullan BR, Schofield PF. Microvascular studies in non-specific inflammatory bowel disease. Gut 1986; 27 (05) 542-549
    CrossrefPubMedGoogle Scholar
  • 54 Angerson WJ, Allison MC, Baxter JN, Russell RI. Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease. Gut 1993; 34 (11) 1531-1534
    CrossrefPubMedGoogle Scholar
  • 55 Coffey CJ, Kiernan MG, Sahebally SM. et al. Inclusion of the mesentery in ileocolic resection for Crohn's disease is associated with reduced surgical recurrence. J Crohn's Colitis 2018; 12 (10) 1139-1150
    CrossrefPubMedGoogle Scholar
  • 56 Baker WN. Ileo-rectal anastomosis for Crohn's disease of the colon. Gut 1971; 12 (06) 427-431
    CrossrefPubMedGoogle Scholar
  • 57 Lindhagen T, Ekelund G, Leandoer L, Hildell J, Lindström C, Wenckert A. Crohn's disease in a defined population course and results of surgical treatment. Part II. Large bowel disease. Acta Chir Scand 1983; 149 (04) 415-421
    PubMedGoogle Scholar
  • 58 Ambrose NS, Keighley MR, Alexander-Williams J, Allan RN. Clinical impact of colectomy and ileorectal anastomosis in the management of Crohn's disease. Gut 1984; 25 (03) 223-227
    CrossrefPubMedGoogle Scholar
  • 59 Jones PF, Keenan RA. The place of colectomy with ileo-rectal anastomosis in inflammatory bowel disease. Ann Chir Gynaecol 1986; 75 (02) 75-81
    PubMedGoogle Scholar
  • 60 Steinberg DM, Allan RN, Cooke WT, Alexander-Williams J. The place of ileorectal anastomosis in Crohn's disease. Aust N Z J Surg 1976; 46 (01) 49-54
    CrossrefPubMedGoogle Scholar
  • 61 Goligher JC. Surgical treatment of Crohn's disease affecting mainly or entirely the large bowel. World J Surg 1988; 12 (02) 186-190
    CrossrefPubMedGoogle Scholar
  • 62 Sciaudone G, Pellino G, Riegler G, Selvaggi F. Infliximab in drug-naïve patients with failed ileorectal anastomosis for Crohn's disease: a new chance for sparing the rectum?. Eur Surg Res 2011; 46 (04) 163-168
    CrossrefPubMedGoogle Scholar
  • 63 McKenna NP, Bews KA, Habermann EB, Dozois EJ, Lightner AL, Mathis KL. What factors are associated with the eventual need for an ileostomy after total abdominal colectomy and ileosigmoid or ileorectal anastomosis for Crohn's colitis in the biologic era?. Dis Colon Rectum 2020; 63 (04) 504-513
    CrossrefPubMedGoogle Scholar
  • 64 Salice M, Rizzello F, Sgambato D. et al. Long term remission after ileorectal anastomosis in Crohn's colitis. Dig Liver Dis 2021; 53 (05) 592-597
    CrossrefPubMedGoogle Scholar
  • 65 Baelum JK, Qvist N, Ellebaek MB. Ileorectal anastomosis in patients with Crohn's disease. Postoperative complications and functional outcome – a systematic review. Colorectal Dis 2021; 23 (10) 2501-2514
    CrossrefPubMedGoogle Scholar
  • 66 Kariv Y, Remzi FH, Strong SA, Hammel JP, Preen M, Fazio VW. Ileal pouch rectal anastomosis: a viable alternative to permanent ileostomy in Crohn's proctocolitis patients. J Am Coll Surg 2009; 208 (03) 390-399
    CrossrefPubMedGoogle Scholar
  • 67 Braveman JM, Schoetz Jr DJ, Marcello PW. et al. The fate of the ileal pouch in patients developing Crohn's disease. Dis Colon Rectum 2004; 47 (10) 1613-1619
    CrossrefPubMedGoogle Scholar
  • 68 Hartley JE, Fazio VW, Remzi FH. et al. Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn's disease. Dis Colon Rectum 2004; 47 (11) 1808-1815
    CrossrefPubMedGoogle Scholar
  • 69 Lightner AL, Pemberton JH, Loftus Jr EJ. Crohn's disease of the ileoanal pouch. Inflamm Bowel Dis 2016; 22 (06) 1502-1508
    CrossrefPubMedGoogle Scholar
  • 70 Tekkis PP, Heriot AG, Smith O, Smith JJ, Windsor AC, Nicholls RJ. Long-term outcomes of restorative proctocolectomy for Crohn's disease and indeterminate colitis. Colorectal Dis 2005; 7 (03) 218-223
    CrossrefPubMedGoogle Scholar
  • 71 Lee PY, Fazio VW, Church JM, Hull TL, Eu KW, Lavery IC. Vaginal fistula following restorative proctocolectomy. Dis Colon Rectum 1997; 40 (07) 752-759
    CrossrefPubMedGoogle Scholar
  • 72 Fazio VW, Kiran RP, Remzi FH. et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013; 257 (04) 679-685
    CrossrefPubMedGoogle Scholar
  • 73 Li Y, Stocchi L, Mu X, Cherla D, Remzi FH. Long-term outcomes of sphincter-saving procedures for diffuse Crohn's disease of the large bowel. Dis Colon Rectum 2016; 59 (12) 1183-1190
    CrossrefPubMedGoogle Scholar
  • 74 Le Q, Melmed G, Dubinsky M. et al. Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease. Inflamm Bowel Dis 2013; 19 (01) 30-36
    CrossrefPubMedGoogle Scholar
  • 75 Panis Y, Poupard B, Nemeth J, Lavergne A, Hautefeuille P, Valleur P. Ileal pouch/anal anastomosis for Crohn's disease. Lancet 1996; 347 (9005): 854-857
    CrossrefPubMedGoogle Scholar
  • 76 Regimbeau JM, Panis Y, Pocard M. et al. Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease. Dis Colon Rectum 2001; 44 (06) 769-778
    CrossrefPubMedGoogle Scholar
  • 77 Lightner AL, Jia X, Zaghiyan K, Fleshner PR. IPAA in known preoperative Crohn's disease: a systematic review. Dis Colon Rectum 2021; 64 (03) 355-364
    CrossrefPubMedGoogle Scholar
  • 78 Sacks GD, Dawes AJ, Ettner SL. et al. Surgeon perception of risk and benefit in the decision to operate. Ann Surg 2016; 264 (06) 896-903
    CrossrefPubMedGoogle Scholar
  • 79 Neary PM, Aiello AC, Stocchi L. et al. High-risk ileocolic anastomoses for Crohn's disease: when is diversion indicated?. J Crohn's Colitis 2019; 13 (07) 856-863
    CrossrefPubMedGoogle Scholar
  • 80 Yoon YS, Stocchi L, Holubar S. et al. When should we add a diverting loop ileostomy to lararoscopic ileocolic resection for primary Crohn's disease?. Surg Endosc 2021; 35 (06) 2543-2557
    CrossrefPubMedGoogle Scholar
  • 81 Myrelid P, Söderholm JD, Olaison G, Sjödahl R, Andersson P. Split stoma in resectional surgery of high-risk patients with ileocolonic Crohn's disease. Colorectal Dis 2012; 14 (02) 188-193
    CrossrefPubMedGoogle Scholar
  • 82 Bolckmans R, Singh S, Ratnatunga K. et al. Temporary faecal diversion in ileocolic resection for Crohn's disease: is there an impact on long-term surgical recurrence?. Colorectal Dis 2020; 22 (04) 430-438
    CrossrefPubMedGoogle Scholar